NTES-S
09999
JD HEALTH
06618
TENCENT
00700
4
JD-SW
09618
5
BABA-W
09988
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | 1.56%580.69B | 0.96%437.8B | 0.15%290.85B | -0.74%144.54B | -3.07%571.75B | -3.22%433.63B | -3.25%290.42B | -3.54%145.61B | 2.06%589.88B | 4.27%448.05B |
-Interest income | 4.25%1.28T | 5.70%962.51B | 7.15%644.05B | 9.66%323.84B | 10.40%1.22T | 10.30%910.59B | 10.75%601.08B | 10.47%295.33B | 9.97%1.11T | 10.29%825.54B |
-Interest expense | -6.60%-694.99B | -10.01%-524.72B | -13.69%-353.2B | -19.76%-179.31B | -25.72%-651.95B | -26.35%-476.96B | -28.08%-310.66B | -28.63%-149.72B | -20.59%-518.58B | -18.40%-377.49B |
Net service income | -5.65%75.57B | -7.65%61.65B | -7.87%46.74B | -10.79%29.04B | -1.46%80.09B | -0.89%66.76B | 2.51%50.73B | 2.78%32.55B | 1.19%81.28B | 2.87%67.36B |
-Service income | -5.01%89.97B | -6.62%72.04B | -6.83%53.68B | -9.53%32.51B | -0.85%94.71B | -0.77%77.14B | 2.48%57.62B | 2.22%35.93B | -3.24%95.52B | -1.88%77.74B |
-Service charge | 1.50%-14.4B | -0.01%-10.38B | -0.83%-6.95B | -2.57%-3.47B | -2.68%-14.62B | 0.02%-10.38B | -2.26%-6.89B | 2.84%-3.38B | 22.60%-14.24B | 24.50%-10.38B |
Net transaction income | 10.30%25.51B | -35.90%22.94B | -0.35%15.76B | -7.17%9.45B | 318.99%23.12B | 105.39%35.79B | 103.74%15.81B | 1,703.90%10.17B | -61.25%5.52B | -33.42%17.43B |
Securities and investments income | 22.97%20.62B | 3,528.57%8.89B | 3.17%11.05B | 317.68%2.71B | 183.70%16.76B | -47.08%245M | 236.07%10.71B | -2,491.67%-1.24B | -60.70%5.91B | 107.85%463M |
Special items of operating revenue | 141.82%9.04B | 438.07%9.38B | 245.49%2.74B | -81.48%422M | -70.55%3.74B | -108.64%-2.77B | -173.13%-1.89B | 9.57%2.28B | -62.84%12.69B | 5.56%32.11B |
Operating revenue | 2.29%711.42B | 1.31%540.66B | 0.37%367.14B | -1.70%186.15B | 0.03%695.47B | -5.62%533.65B | 0.72%365.79B | 2.24%189.37B | -3.67%695.28B | 3.58%565.4B |
Operating expenses - before deducting impairment | -3.52%-261.18B | -0.84%-168.21B | -0.93%-108.68B | -2.31%-51.08B | -3.59%-252.31B | 10.87%-166.81B | -5.85%-107.68B | -5.03%-49.92B | 6.42%-243.57B | -8.01%-187.16B |
Operating profit before deducting impairment | 1.60%450.24B | 1.53%372.45B | 0.13%258.46B | -3.14%135.07B | -1.89%443.16B | -3.01%366.84B | -1.28%258.12B | 1.28%139.44B | -2.11%451.71B | 1.52%378.24B |
Impairment and provisions | 3.55%-131.11B | -1.18%-131.15B | 1.32%-101.03B | 1.59%-55.63B | 6.46%-135.93B | 9.72%-129.62B | 3.00%-102.38B | -6.89%-56.53B | 12.45%-145.33B | -1.38%-143.58B |
-Impairment losses of other assets | 3.55%-131.11B | -1.18%-131.15B | 1.32%-101.03B | 1.59%-55.63B | 6.46%-135.93B | 9.72%-129.62B | 3.00%-102.38B | -6.89%-56.53B | 12.45%-145.33B | -1.38%-143.58B |
Operating profit after deducting impairment | 3.87%319.13B | 1.72%241.31B | 1.09%157.43B | -4.19%79.44B | 0.28%307.23B | 1.09%237.22B | -0.12%155.74B | -2.22%82.92B | 3.69%306.39B | 1.60%234.66B |
Operating profit | 3.87%319.13B | 1.72%241.31B | 1.09%157.43B | -4.19%79.44B | 0.28%307.23B | 1.09%237.22B | -0.12%155.74B | -2.22%82.92B | 3.69%306.39B | 1.60%234.66B |
Share of profits of associates | -61.90%72M | -79.89%38M | -82.40%41M | -104.50%-5M | 186.36%189M | 71.82%189M | 79.23%233M | -67.64%111M | -83.86%66M | -66.46%110M |
Earning before tax | 3.83%319.2B | 1.66%241.35B | 0.96%157.47B | -4.32%79.44B | 0.32%307.42B | 1.13%237.41B | -0.05%155.97B | -2.48%83.03B | 3.57%306.45B | 1.50%234.77B |
Tax | 2.84%-36.53B | 11.94%-26.08B | 5.24%-20.98B | 21.19%-8.6B | 20.99%-37.6B | 20.94%-29.62B | 18.81%-22.14B | 27.29%-10.91B | 11.78%-47.59B | 14.70%-37.47B |
After-tax profit from continuing operations | 4.76%282.67B | 3.60%215.26B | 1.99%136.49B | -1.77%70.84B | 4.23%269.82B | 5.32%207.79B | 3.92%133.83B | 2.83%72.12B | 7.00%258.87B | 5.30%197.3B |
Earning After tax | 4.76%282.67B | 3.60%215.26B | 1.99%136.49B | -1.77%70.84B | 4.23%269.82B | 5.32%207.79B | 3.92%133.83B | 2.83%72.12B | 7.00%258.87B | 5.30%197.3B |
Minority profit | 26.72%588M | 105.54%890M | 0.84%602M | -19.25%453M | 226.78%464M | 312.25%433M | 1,825.81%597M | 396.83%561M | -148.61%-366M | -130.86%-204M |
Profits attributable to shareholders | 4.72%282.08B | 3.38%214.37B | 1.99%135.89B | -1.63%70.39B | 3.91%269.36B | 4.99%207.36B | 3.48%133.23B | 1.75%71.55B | 7.48%259.23B | 5.78%197.51B |
Basic earnings per share | 4.17%0.75 | 1.82%0.56 | 0.00%0.37 | -5.00%0.19 | 4.35%0.72 | 3.77%0.55 | 5.71%0.37 | 0.00%0.2 | 6.15%0.69 | 6.00%0.53 |
Diluted earnings per share | 4.17%0.75 | 1.82%0.56 | 0.00%0.37 | -5.00%0.19 | 4.35%0.72 | 3.77%0.55 | 5.71%0.37 | 0.00%0.2 | 6.15%0.69 | 6.00%0.53 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.